Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents

Metastasis is the leading cause of cancer-related deaths and despite measurable progress in the field, underlying mechanisms are still not fully understood. Circulating tumor cells (CTCs) disseminate within the bloodstream, where most of them die due to the attack of the immune system. On the other hand, recent evidence shows active interactions between CTCs and platelets, myeloid cells, macrophages, neutrophils, and other hematopoietic cells that secrete immunosuppressive cytokines, which aid CTCs to evade the immune system and enable metastasis. Platelets, for instance, regulate inflammation, recruit neutrophils, and cause fibrin clots, which may protect CTCs from the attack of Natural Killer cells or macrophages and facilitate extravasation. Recently, a correlation between the commensal microbiota and the inflammatory/immune tone of the organism has been stablished. Thus, the microbiota may affect the development of cancer-promoting conditions. Furthermore, CTCs may suffer phenotypic changes, as those caused by the epithelial–mesenchymal transition, that also contribute to the immune escape and resistance to immunotherapy. In this review, we discuss the findings regarding the collaborative biological events among CTCs, immune cells, and microbiome associated to immune escape and metastatic progression.

[1]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[2]  C. Gerhauser Impact of dietary gut microbial metabolites on the epigenome , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[3]  S. Lightfoot,et al.  Dclk1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition , 2014, Oncotarget.

[4]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[5]  Wenguang Liu,et al.  Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation , 2016, Tumor Biology.

[6]  P. Mukherjee,et al.  Role of Microbiome in Modulating Immune Responses in Cancer , 2019, Mediators of inflammation.

[7]  George Coukos,et al.  Cancer immunotherapy comes of age , 2011, Nature.

[8]  M. Huycke,et al.  Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect , 2014, Gut.

[9]  H. Yim,et al.  Microbial Factors in Inflammatory Diseases and Cancers. , 2017, Advances in experimental medicine and biology.

[10]  J. Pollard,et al.  Immune cell promotion of metastasis , 2015, Nature Reviews Immunology.

[11]  L. Tang,et al.  Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein , 2014, Nature Communications.

[12]  D. Shu,et al.  Microbial metabolite butyrate facilitates M2 macrophage polarization and function , 2016, Scientific Reports.

[13]  Yingqiu Xie,et al.  Role of Yes-associated protein in cancer: An update , 2016, Oncology letters.

[14]  P. Zhang,et al.  Gut microbiome and cancer immunotherapy. , 2019, Cancer letters.

[15]  H. Harmsen,et al.  The role of the microbiome for human health: from basic science to clinical applications , 2018, European Journal of Nutrition.

[16]  Andreas H. Nuber,et al.  Long-lived intestinal tuft cells serve as colon cancer-initiating cells. , 2014, The Journal of clinical investigation.

[17]  Lesley M. Chapman,et al.  Emerging roles for platelets as immune and inflammatory cells. , 2014, Blood.

[18]  P. Traber,et al.  Cancer in inflammatory bowel disease. , 1994, The Medical clinics of North America.

[19]  K. Peremans,et al.  Crosstalk between the microbiome and cancer cells by quorum sensing peptides , 2015, Peptides.

[20]  K. D. de Visser,et al.  Immune regulation of metastasis: mechanistic insights and therapeutic opportunities , 2018, Disease Models & Mechanisms.

[21]  M. Colombo,et al.  Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. , 2008, Cancer research.

[22]  D. Pardoll,et al.  Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. , 2018, Cell host & microbe.

[23]  C. Sears,et al.  Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. , 2014, The Journal of clinical investigation.

[24]  C. Logsdon,et al.  The immune system in cancer metastasis: friend or foe? , 2017, Journal of Immunotherapy for Cancer.

[25]  F. Gao,et al.  Fusobacterium nucleatum promotes the progression of colorectal cancer by interacting with E-cadherin. , 2018, Oncology letters.

[26]  Mingyang Song,et al.  Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis , 2015, Gut.

[27]  P. Metharom,et al.  Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis , 2017, International Journal of Molecular Sciences.

[28]  Yongzhi Yang,et al.  Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. , 2017, Gastroenterology.

[29]  Gary An,et al.  Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model , 2014, Theoretical Biology and Medical Modelling.

[30]  Michael C. Schmid,et al.  Macrophages as Key Drivers of Cancer Progression and Metastasis , 2017, Mediators of inflammation.

[31]  R. Zamarchi,et al.  The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy , 2018, Diagnostics.

[32]  J. Lorente,et al.  Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients , 2018, Journal of Translational Medicine.

[33]  J. Italiano,et al.  The incredible journey: From megakaryocyte development to platelet formation , 2013, The Journal of cell biology.

[34]  G. Gambassi,et al.  The Microbiota and Immune System Crosstalk in Health and Disease , 2018, Mediators of inflammation.

[35]  D. Xiu,et al.  Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma , 2016, Medicine.

[36]  Nailin Li Platelets in cancer metastasis: To help the “villain” to do evil , 2016, International journal of cancer.

[37]  Yong‐Nyun Kim,et al.  Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis , 2012, International journal of cell biology.

[38]  S. Margetić Inflammation and haemostasis , 2012, Biochemia medica.

[39]  Georg Krupitza,et al.  Initial steps of metastasis: Cell invasion and endothelial transmigration , 2011, Mutation research.

[40]  D. Haber,et al.  A conduit to metastasis: circulating tumor cell biology , 2017, Genes & development.

[41]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[42]  M. Salido,et al.  EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer , 2014, Oncotarget.

[43]  N. Hyman,et al.  How the microbiome is shaping our understanding of cancer biology and its treatment , 2017 .

[44]  Jian Zhang,et al.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression , 2010, Cancer and Metastasis Reviews.

[45]  K. Miyazono,et al.  ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets , 2017, Cell Death and Differentiation.

[46]  Ying-Chih Chang,et al.  Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients , 2016, Scientific Reports.

[47]  I. Lizasoain,et al.  Neutrophils scan for activated platelets to initiate inflammation , 2014, Science.

[48]  R. Cummings,et al.  P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin , 1995, The Journal of cell biology.

[49]  P. Hofman,et al.  Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment , 2019, Cells.

[50]  E. Dias-Neto,et al.  The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer. , 2019, The oncologist.

[51]  Katarzyna A Rejniak,et al.  Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment. , 2016, Advances in experimental medicine and biology.

[52]  Dariusz Szukiewicz,et al.  The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis , 2014, Mediators of inflammation.

[53]  O. Reséndis-Antonio,et al.  Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine , 2016, Front. Physiol..

[54]  A. Moustakas,et al.  Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β , 2018, International journal of molecular sciences.

[55]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[56]  P. Wee,et al.  Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways , 2017, Cancers.

[57]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[58]  P. Godowski,et al.  Toll-Like Receptor 2 Ligands as Adjuvants for Human Th1 Responses1 , 2003, The Journal of Immunology.

[59]  C. Dubois,et al.  Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis , 2018, Cancers.

[60]  K. M. McSweeney,et al.  Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases , 2019, Cancer and Metastasis Reviews.

[61]  Corrie M. Whisner,et al.  The Role of the Microbiome in Cancer Initiation and Progression: How Microbes and Cancer Cells Utilize Excess Energy and Promote One Another’s Growth , 2019, Current Nutrition Reports.

[62]  T. Fehm,et al.  Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer. , 2013, Anticancer Research.

[63]  R. May,et al.  Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells , 2016, Journal of carcinogenesis & mutagenesis.

[64]  B. Rath,et al.  Circulating tumor cell interactions with macrophages: implications for biology and treatment. , 2017, Translational lung cancer research.

[65]  Sebastian G Strobel,et al.  Cancer in inflammatory bowel disease: lessons from animal models , 2012, Current opinion in gastroenterology.

[66]  M. R. Rubinstein,et al.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.

[67]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions: insights from development , 2012, Development.

[68]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[69]  M. Delgado-Rodríguez,et al.  Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection , 2016, PloS one.